LYELL IMMUNOPHARMA INC
LYELNASDAQ๐ #3065 by market capEarnings Mar 12 ยท PreUS Equity
$13.80โฒ $0.22 (+1.62%)
Market closed ยท at closeTrack LYEL
Get earnings, price moves & breaking news on Telegram
24hโฒ 1.6%
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$339M
Small Cap
๐Revenue Growth (YoY)
-41.0%
Declining
๐Gross Margin
-15446.7%
Thin
๐ตFCF Margin
-933100.0%
Thin
โ๏ธP/S Ratio
22618.7x
Expensive
Otter Score
24
Weak
LYELL IMMUNOPHARMA INC
LYELAnalyst Ratings
Price
$13.80
Total
7
Raised
0
Lowered
3
Avg PT
$39.50
H / L
$45 / $34
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-11-03 | $45.00 | +226.10% |
Citizens | Reiterated | Market Outperform | 2026-06-15 | โ | โ |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-09 | โ | โ |
B of A Securities | Downgraded | Buy โ Underperform | 2024-10-30 | โ | โ |
JP Morgan | Downgraded | Overweight โ Neutral | 2023-08-28 | โ | โ |
Morgan Stanley | Reiterated | Equal Weight | 2023-01-24 | $7.00 | โ49.30% |
Goldman Sachs | Downgraded | Buy โ Neutral | 2022-11-11 | $12.00 | โ13.00% |
Institution
Needham
Reiterated ยท Buy ยท 2026-11-03
$45.00
+226.10%
Citizens
Reiterated ยท Market Outperform ยท 2026-06-15
โ
โ
HC Wainwright & Co.
Reiterated ยท Buy ยท 2026-06-09
โ
โ
B of A Securities
Downgraded ยท Buy โ Underperform ยท 2024-10-30
โ
โ
JP Morgan
Downgraded ยท Overweight โ Neutral ยท 2023-08-28
โ
โ
Morgan Stanley
Reiterated ยท Equal Weight ยท 2023-01-24
$7.00
โ49.30%
Goldman Sachs
Downgraded ยท Buy โ Neutral ยท 2022-11-11
$12.00
โ13.00%
One row per institution ยท price target from the firm's latest published target